Literature DB >> 15138603

Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12.

Jana Mackova1, Luda Kutinova, Petr Hainz, Jitka Krystofova, Vojtech Sroller, Pavel Otahal, Pavel Gabriel, Sarka Nemeckova.   

Abstract

Dendritic cells (DC) enhanced the immunogenicity of recombinant vaccinia viruses (rVV) expressing the E7 protein of HPV16, a tumor-associated antigen (TAA). Immunization with DC transduced by rVV generated from strain Praha or MVA induced better protection against the growth of transplanted TC-1 tumors in C57Bl/6 mice than did immunization with either of these rVVs administered alone by the same route. Interestingly, DC transduced with a double recombinant vaccinia virus expressing E7 protein together with the Th1-polarizing cytokine IL12, which has been shown to enhance the cellular response in several other systems, induced lower anti-tumor immunity than DC transduced with rVV expressing E7 protein alone. The inhibitory effect mediated by IL12 on immunization with rVV-infected DC was dose-dependent and was observed after immunization with DC transduced with IL12-expressing rVV even at low multiplicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138603

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Authors:  J Musil; L Kutinova; K Zurkova; P Hainz; K Babiarova; J Krystofova; S Nemeckova
Journal:  Cancer Gene Ther       Date:  2014-02-21       Impact factor: 5.987

Review 2.  Current state in the development of candidate therapeutic HPV vaccines.

Authors:  Andrew Yang; Jessica Jeang; Kevin Cheng; Ting Cheng; Benjamin Yang; T-C Wu; Chien-Fu Hung
Journal:  Expert Rev Vaccines       Date:  2016-03-07       Impact factor: 5.217

Review 3.  Immunotherapy for cervical cancer: Research status and clinical potential.

Authors:  Jun-Han Su; Anjui Wu; Elizabeth Scotney; Barbara Ma; Archana Monie; Chien-Fu Hung; T-C Wu
Journal:  BioDrugs       Date:  2010-04-01       Impact factor: 5.807

Review 4.  Perspectives for preventive and therapeutic HPV vaccines.

Authors:  Ken Lin; Kimberley Doolan; Chien-Fu Hung; T C Wu
Journal:  J Formos Med Assoc       Date:  2010-01       Impact factor: 3.282

Review 5.  Therapeutic human papillomavirus vaccines: current clinical trials and future directions.

Authors:  Chien-Fu Hung; Barbara Ma; Archana Monie; Shaw-Wei Tsen; T-C Wu
Journal:  Expert Opin Biol Ther       Date:  2008-04       Impact factor: 4.388

Review 6.  The current state of therapeutic and T cell-based vaccines against human papillomaviruses.

Authors:  Andrew Yang; Emily Farmer; John Lin; T-C Wu; Chien-Fu Hung
Journal:  Virus Res       Date:  2016-12-06       Impact factor: 3.303

Review 7.  Cervical Cancer Immunotherapy: Facts and Hopes.

Authors:  Louise Ferrall; Ken Y Lin; Richard B S Roden; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2021-04-22       Impact factor: 12.531

Review 8.  Perspectives for therapeutic HPV vaccine development.

Authors:  Andrew Yang; Emily Farmer; T C Wu; Chien-Fu Hung
Journal:  J Biomed Sci       Date:  2016-11-04       Impact factor: 8.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.